Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Europe symbols : AXSM save search
Axsome Therapeutics Enters into License Agreement with Pharmanovia to Expand Commercialization and Further Develop Sunosi® (solriamfetol) in Europe
Published: 2023-02-22 (Crawled : 13:00) - biospace.com/
MS | News 0 d | $90.86 0.66% 4.7M
|
Finance
|
| O: -0.26%
H: 0.72%
C: -0.1%
AXSM | $66.75 1.57% 530K
|
Health Technology
|
| O: 1.21%
H: 1.23%
C: -2.52%
sunosi europe commercialization license therapeutics agreement solriamfetol
Jazz Pharmaceuticals Completes U.S. Divestiture of Sunosi® (solriamfetol) to Axsome Therapeutics
Published: 2022-05-09 (Crawled : 12:00) - biospace.com/
JAZZ | $110.6 1.22% 210K
|
Health Technology
|
| O: -1.4%
H: 0.61%
C: -4.73%
AXSM | $66.75 1.57% 530K
|
Health Technology
|
| O: -17.99%
H: 1.48%
C: -7.64%
sunosi therapeutics solriamfetol
Gainers vs Losers
| 70% | 30% |
Top 10 Gainers
AGBA | News | $1.305 226.25% 130M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
NVFY | $2.65 25.59% 33M
|
Consumer Durables
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.